geraniin has been researched along with Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Fu, Y; Huang, H; Li, J; Liu, X; Meng, X; Wang, X; Yu, B; Zhou, X | 1 |
| Alexandra, PTAA; Cheng, HS; Goh, BH; Palanisamy, UD; Tan, JBL; Ting, KN | 1 |
| Moorthy, M; Palanisamy, UD; Perera, A; Ton, SH | 1 |
3 other study(ies) available for geraniin and Obesity
| Article | Year |
|---|---|
Geraniin targeting CaMKK2 inhibits lipid accumulation in 3T3-L1 adipocytes by suppressing lipogenesis.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Lipid Metabolism; Lipids; Lipogenesis; Mice; Molecular Docking Simulation; Obesity; PPAR gamma; Transcription Factors | 2023 |
Geraniin Ameliorates Hypertensive Vascular Remodelling in a Diet-Induced Obese Animal Model through Antioxidant and Anti-Inflammatory Effects.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Captopril; Diet, High-Fat; Hydrolyzable Tannins; Hypertension; Male; Models, Animal; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2023 |
The insulin-sensitising properties of the ellagitannin geraniin and its metabolites from
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Biological Transport; Cell Differentiation; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Glucosides; Hydrolyzable Tannins; Hyperglycemia; Insulin; Lipolysis; Mice; Obesity; Plant Extracts; Sapindaceae | 2020 |